The risk of colorectal cancer in inflammatory bowel disease: a hospital-based cohort study from Korea

References

• Eaden JA, Abrams KR, Mayberry JF. The risk of colorectal cancer in ulcerative colitis: a meta-analysis. Gut 2001;48:526–35.
   PubMed Web of Science ®Google Scholar
• Castano-Milla C, Chaparro M, Gisbert JP. Systematic review with meta-analysis: the declining risk of colorectal cancer in ulcerative colitis. Aliment Pharmacol Ther 2014;39:645–59.
   PubMed Web of Science ®Google Scholar
• Lutgens MW, van Oijen MG, van der Heijden GJ, Vleggaar FP, Siersema PD, Oldenburg B. Declining risk of colorectal cancer in inflammatory bowel disease: an updated meta-analysis of population-based cohort studies. Inflamm Bowel Dis 2013;19:789–99.
   PubMed Web of Science ®Google Scholar
• Jess T, Loftus EVJr, Velayos FS, Harmsen WS, Zinsmeister AR, Smyrk TC, et al. Risk of intestinal cancer in inflammatory bowel disease: a population-based study from olmsted county, Minnesota. Gastroenterology 2006;130:1039–46.
   PubMed Web of Science ®Google Scholar
• Jess T, Simonsen J, Jorgensen KT, Pedersen BV, Nielsen NM, Frisch M. Decreasing risk of colorectal cancer in patients with inflammatory bowel disease over 30 years. Gastroenterology 2012;143:375–81.
   PubMed Web of Science ®Google Scholar
• Kim BJ, Yang SK, Kim JS, Jeen YT, Choi H, Han DS, et al. Trends of ulcerative colitis-associated colorectal cancer in Korea: A KASID study. J Gastroenterol Hepatol 2009;24:667–71.
   PubMed Web of Science ®Google Scholar
• Gong W, Lv N, Wang B, Chen Y, Huang Y, Pan W, et al. Risk of ulcerative colitis-associated colorectal cancer in China: a multi-center retrospective study. Dig Dis Sci 2012;57:503–7.
   PubMedGoogle Scholar
• Yano Y, Matsui T, Hirai F, Okado Y, Sato Y, Tsurumi K, et al. Cancer risk in Japanese Crohn’s disease patients: investigation of the standardized incidence ratio. J Gastroenterol Hepatol 2013;28:1300–5.
   PubMed Web of Science ®Google Scholar
• Park SH, Kim YM, Yang SK, Kim SH, Byeon JS, Myung SJ, et al. Clinical features and natural history of ulcerative colitis in Korea. Inflamm Bowel Dis 2007;13:278–83.
   PubMed Web of Science ®Google Scholar
• Yang SK, Yun S, Kim JH, Park JY, Kim HY, Kim YH, et al. Epidemiology of inflammatory bowel disease in the Songpa-Kangdong district, Seoul, Korea, 1986-2005: a KASID study. Inflamm Bowel Dis 2008;14:542–9.
   PubMed Web of Science ®Google Scholar
• Ye BD, Yang SK, Cho YK, Park SH, Yang DH, Yoon SM, et al. Clinical features and long-term prognosis of Crohn’s disease in Korea. Scand J Gastroenterol 2010;45:1178–85.
   PubMed Web of Science ®Google Scholar
• Park SH, Yang SK, Park SK, Kim JW, Yang DH, Jung KW, et al. Long-term prognosis of crohn’s disease and its temporal change between 1981 and 2012: a hospital-based cohort study from Korea. Inflamm Bowel Dis 2014;20:488–94.
   PubMed Web of Science ®Google Scholar
• Cairns SR, Scholefield JH, Steele RJ, Dunlop MG, Thomas HJ, Evans GD, et al. Guidelines for colorectal cancer screening and surveillance in moderate and high risk groups (update from 2002). Gut 2010;59:666–89.
   PubMed Web of Science ®Google Scholar
• Van Assche G, Dignass A, Bokemeyer B, Danese S, Gionchetti P, Moser G, et al. Second European evidence-based consensus on the diagnosis and management of ulcerative colitis part 3: special situations. J Crohns Colitis 2013;7:1–33.
   PubMed Web of Science ®Google Scholar
• Annese V, Daperno M, Rutter MD, Amiot A, Bossuyt P, East J, et al. European evidence based consensus for endoscopy in inflammatory bowel disease. J Crohns Colitis 2013;7:982–1018.
   PubMed Web of Science ®Google Scholar
• Edge S, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A. AJCC cancer staging manual. 7th edition. Springer; New York: 2010.
   Google Scholar
• Korean Statistical Information Service. Available from http://kosis.kr/statHtml/statHtml.do?orgId=117&tblId=DT_117N_A00023&conn_path=I3.
   Google Scholar
• R software version 3.0.2. Available from http://www.r-project.org.
   Google Scholar
• Lakatos L, Mester G, Erdelyi Z, David G, Pandur T, Balogh M, et al. Risk factors for ulcerative colitis-associated colorectal cancer in a Hungarian cohort of patients with ulcerative colitis: results of a population-based study. Inflamm Bowel Dis 2006;12:205–11.
   PubMed Web of Science ®Google Scholar
• Probert CS, Warren BF, Perry T, Mackay EH, Mayberry JF, Corfield AP. South Asian and European colitics show characteristic differences in colonic mucus glycoprotein type and turnover. Gut 1995;36:696–702.
   PubMedGoogle Scholar
• Iesalnieks I, Gaertner WB, Glass H, Strauch U, Hipp M, Agha A, et al. Fistula-associated anal adenocarcinoma in Crohn’s disease. Inflamm Bowel Dis 2010;16:1643–8.
   PubMed Web of Science ®Google Scholar
• Bernstein CN, Blanchard JF, Kliewer E, Wajda A. Cancer risk in patients with inflammatory bowel disease: a population-based study. Cancer 2001;91:854–62.
   PubMed Web of Science ®Google Scholar
• Jess T, Winther KV, Munkholm P, Langholz E, Binder V. Intestinal and extra-intestinal cancer in Crohn’s disease: follow-up of a population-based cohort in Copenhagen County, Denmark. Aliment Pharmacol Ther 2004;19:287–93.
   PubMed Web of Science ®Google Scholar
• Jess T, Gamborg M, Matzen P, Munkholm P, Sorensen TI. Increased risk of intestinal cancer in Crohn’s disease: a meta-analysis of population-based cohort studies. Am J Gastroenterol 2005;100:2724–9.
   PubMed Web of Science ®Google Scholar
• Mizushima T, Ohno Y, Nakajima K, Kai Y, Iijima H, Sekimoto M, et al. Malignancy in Crohn’s disease: incidence and clinical characteristics in Japan. Digestion 2010;81:265–70.
   PubMedGoogle Scholar
• Kim JY, Yang SK, Byeon JS, Myung SJ, Choe JW, Jo JY, et al. The incidence and natural history of perianal fistulas in Korean patients with Crohn’s disease [Korean]. Intest Res 2006;4:22–31.
   Google Scholar
• Watanabe T, Konishi T, Kishimoto J, Kotake K, Muto T, Sugihara K, et al. Ulcerative colitis-associated colorectal cancer shows a poorer survival than sporadic colorectal cancer: a nationwide Japanese study. Inflamm Bowel Dis 2011;17:802–8.
   PubMed Web of Science ®Google Scholar
• Brackmann S, Andersen SN, Aamodt G, Roald B, Langmark F, Clausen OP, et al. Two distinct groups of colorectal cancer in inflammatory bowel disease. Inflamm Bowel Dis 2009;15:9–16.
   PubMedGoogle Scholar
• Beaugerie L, Svrcek M, Seksik P, Bouvier AM, Simon T, Allez M, et al. Risk of colorectal high-grade dysplasia and cancer in a prospective observational cohort of patients with inflammatory bowel disease. Gastroenterology 2013;145:166–75.
   PubMed Web of Science ®Google Scholar
• Ali RA, Dooley C, Comber H, Newell J, Egan LJ. Clinical features, treatment, and survival of patients with colorectal cancer with or without inflammatory bowel disease. Clin Gastroenterol Hepatol 2011;9:584–9.
   PubMedGoogle Scholar
• Wu X, Chen VW, Martin J, Roffers S, Groves FD, Correa CN, et al. Subsite-specific colorectal cancer incidence rates and stage distributions among Asians and Pacific Islanders in the United States, 1995 to 1999. Cancer Epidemiol Biomarkers Prev 2004;13:1215–22.
   PubMedGoogle Scholar
• Saltzstein SL, Behling CA. Age and time as factors in the left-to-right shift of the subsite of colorectal adenocarcinoma: a study of 213,383 cases from the California Cancer Registry. J Clin Gastroenterol 2007;41:173–7.
   PubMedGoogle Scholar